tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CLRB Stock Latest News

Cellectar Biosciences price target raised to $28 from $20 at Roth MKM
The FlyCellectar Biosciences price target raised to $28 from $20 at Roth MKM
29d ago
CLRB
Cellectar Biosciences price target raised to $12 from $11 at Oppenheimer
PremiumThe Fly
Cellectar Biosciences price target raised to $12 from $11 at Oppenheimer
29d ago
CLRB
Options Volatility and Implied Earnings Moves Today, March 27, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, March 27, 2024
1M ago
CC
RH
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
PremiumPress Releases
Cellectar Biosciences Reports Financial Results for Year Ended 2023 and Provides a Corporate Update
1M ago
CLRB
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
PremiumMarket News
Options Volatility and Implied Earnings Moves This Week, March 26 – March 28, 2024
1M ago
PL
RH
Cellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024
PremiumPress ReleasesCellectar Biosciences to Announce 2023 Year End Earnings Results and Host a Conference Call on Wednesday, March 27, 2024
1M ago
CLRB
CLRB Upcoming Earnings Report: What to Expect?
PremiumPre-Earnings
CLRB Upcoming Earnings Report: What to Expect?
1M ago
CLRB
Cellectar Biosciences to Present at the 36th Annual Roth Conference
PremiumPress Releases
Cellectar Biosciences to Present at the 36th Annual Roth Conference
1M ago
CLRB
Cellectar Bio reports ‘impressive’ efficacy in Phase 1 trial, says Roth MKM
PremiumThe Fly
Cellectar Bio reports ‘impressive’ efficacy in Phase 1 trial, says Roth MKM
2M ago
CLRB
Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
PremiumPress Releases
Cellectar Biosciences Reports High Rate of Complete Remission in Investigator Initiated Phase I Study of Iopofosine in Combination with External Beam Radiotherapy in Recurrent Head and Neck Cancer
2M ago
CLRB
Cellectar Biosciences reports results from Phase 1 study of iopofosine I 131
PremiumThe Fly
Cellectar Biosciences reports results from Phase 1 study of iopofosine I 131
2M ago
CLRB
Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
PremiumPress Releases
Cellectar Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
3M ago
CLRB
Cellectar Biosciences Announces Recent Share Issuance Update
PremiumCompany AnnouncementsCellectar Biosciences Announces Recent Share Issuance Update
3M ago
8K
CLRB
Biotech Alert: Searches spiking for these stocks today
PremiumThe Fly
Biotech Alert: Searches spiking for these stocks today
3M ago
NBY
PTN
One new option listing and two option delistings on January 31st
PremiumThe Fly
One new option listing and two option delistings on January 31st
3M ago
ARVL
CLRB
Cellectar Biosciences enrolls first patient in pediatric glioma Phase 1b study
PremiumThe Fly
Cellectar Biosciences enrolls first patient in pediatric glioma Phase 1b study
3M ago
CLRB
Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study
PremiumPress Releases
Cellectar Biosciences Announces Enrollment of the First Patient in Pediatric High-Grade Gliomas Phase 1b Clinical Study
3M ago
CLRB
Cellectar Biosciences Exercises Tranche A Warrants for $44.1M
PremiumMarket News
Cellectar Biosciences Exercises Tranche A Warrants for $44.1M
3M ago
8K
CLRB
Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million
PremiumPress Releases
Cellectar Biosciences Announces Tranche A Warrants Fully Exercised, Providing Proceeds of $44.1 Million
3M ago
CLRB
Cellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient
PremiumPress ReleasesCellectar Biosciences Reports Complete Central Nervous System (CNS) Clearance in Relapsed/Refractory Waldenstrom’s Macroglobulinemia Patient
3M ago
CLRB
Cellectar Biosciences’ iopofosine conjugate shows efficacy in CNS malignancies
PremiumThe Fly
Cellectar Biosciences’ iopofosine conjugate shows efficacy in CNS malignancies
3M ago
CLRB
Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
PremiumPress Releases
Cellectar Biosciences Broadens Pipeline with Targeted Alpha Therapy (TAT) for Solid Tumors and Releases Promising Preclinical Data
3M ago
CLRB

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >